Literature DB >> 15464514

Primary solitary endobronchial plasmacytoma.

Evgeny Edelstein1, Anthony A Gal, Karen P Mann, Joseph I Miller, Kamal A Mansour.   

Abstract

Twenty-two cases of pulmonary plasmacytoma have been reported in the literature and verified by immunohistochemistry or other diagnostic tests. The treatment for this rare tumor has included various combinations of surgical resection, chemotherapy, and radiation therapy. We report a case of a middle-age man who underwent endoscopic debulking followed by laser ablation for a pulmonary plasmacytoma, which showed a prominent endobronchial location with clinical and histopathologic verification.

Entities:  

Mesh:

Year:  2004        PMID: 15464514     DOI: 10.1016/S0003-4975(03)01474-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Extramedullary endobronchial plasmacytoma.

Authors:  Sebastián Fernández-Bussy; Gonzalo Labarca; Erik Folch; Adnan Majid
Journal:  BMJ Case Rep       Date:  2013-01-09

2.  Primary endobronchial plasmacytoma involving local lymph nodes and presenting with rare immunoglobulin G lambda monoclonal gammopathy.

Authors:  Sen Wei; Xin Li; Zuoqing Song; Honglin Zhao; Xiaomin Qiu; Lei Gong; Jun Chen; Qinghua Zhou
Journal:  Can Respir J       Date:  2012 May-Jun       Impact factor: 2.409

3.  Primary pulmonary plasmacytoma presenting with rare IgG lambda monoclonal gammopathy.

Authors:  Yasmin Rahim; Farrukh Zia Tareen; Rashida Ahmed; Javaid Ahmed Khan
Journal:  BMJ Case Rep       Date:  2019-03-06

4.  A rare case of primary solitary endobronchial plasmacytoma.

Authors:  Jong Il Park; Yin Young Lee; Seok Soo Lee; June Hong Ahn
Journal:  Thorac Cancer       Date:  2021-01-27       Impact factor: 3.500

5.  Primary pulmonary plasmacytoma accompanied by overlap syndrome: A case report and review of the literature.

Authors:  Yi Zhou; Xiao-Hong Wang; Shuang-Shuang Meng; Hui-Chao Wang; Yu-Xia Li; Rui Xu; Xu-Hong Lin
Journal:  World J Clin Cases       Date:  2020-10-26       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.